CD4 and cancer: In some cancers, the presence of invasive CD8+ T lymphocytes is associated with improved prognosis, while CD4+ T lymphocytes, myeloid suppressor cells (MDSCs) and T regulatory cells (Tregs) are negatively correlated with survival [32].